Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

334.22 +5.77 (+1.76%)
Streaming Delayed Price Updated: 2:06 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
26 27 Next >
Morgan Stanley Upgrades Cigna On Humira Prospects
Cigna Corp (NYSE: CI) is poised to benefit from the launch of bioequivalent Humira in July 2023, according to Morgan Stanley. 
Via Benzinga
AM Best Revises Issuer Credit Rating Outlook to Positive for Cigna Corporation and Most of Its Subsidiaries; Affirms Credit Ratings
From AM Best
Via Business Wire
The Shoreline Recovery Center Alcohol and Drug Rehab San Diego Celebrating the 5th Year of the Joint Commission Accreditation
Via GetFeatured
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022
Upgrades 
Via Benzinga
What 15 Analyst Ratings Have To Say About Cigna
Within the last quarter, Cigna (NYSE:CI) has observed the following analyst ratings: 
Via Benzinga
Futures, Oil Tumble As Attention Turns To Coming Recession, Powell Senate Testimony
Tuesday's euphoric market mood has U-turned into sheer despair with most of yesterday's gains gone overnight as attention turns to the coming US recession. 
Via Talk Markets
10 Biggest Price Target Changes For Wednesday: Verizon, PayPal, Kellogg, Dow, Bed Bath & Beyond, Booking And More
RBC Capital cut Verizon Communications Inc. (NYSE: VZ) price target from $57 to $54. Verizon shares fell 0.9% to $50.22 in pre-market trading. 
Via Benzinga
The Path Of Least Resistance, Part II - A Crash Is Coming
The stock market is a two-way street, and right now, the side with the least resistance is 
Via Talk Markets
Analyzing Cigna's Short Interest
Cigna's (NYSE:CI) short percent of float has fallen 6.8% since its last report. The company recently reported that it has 3.00 million shares sold short, which is 0.96% of all... 
Via Benzinga
7 Behavioral Health Tips for Older Adults
Via StatePoint Media
14 Analysts Have This to Say About Cigna
Cigna (NYSE:CI) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Here's Why RBC Capital Raised Price Target On Cigna
Via Benzinga
10 Analysts Have This to Say About Cigna
Analysts have provided the following ratings for Cigna (NYSE:CI) within the last quarter: 
Via Benzinga
What Are Whales Doing With Cigna
Someone with a lot of money to spend has taken a bullish stance on Cigna (NYSE:CI). And retail traders should know. We noticed this today when the big position showed up on publicly available options... 
Via Benzinga
7 of the Hottest ETFs to Buy Right Now
These are the hottest ETFs to buy in June whether you're looking for discounts or ETFs that are already on the move. 
Via InvestorPlace
Enhanced General and Cosmetic Dentistry by iHeartDDS Valencia Dentist in Valencia, CA
Via GetFeatured
$1000 Invested In Cigna 10 Years Ago Would Be Worth This Much
Cigna (NYSE:CI) has outperformed the market over the past 10 years by 7.87% on an annualized basis producing an average annual return of 19.99%. Currently, Cigna has a market capitalization of $86.15... 
Via Benzinga
7 Growth Stocks to Buy Before They Make a Big Comeback
These are the best growth stocks to buy in June. GOOGL, GOOG, AMAT, CMG, FTXL, SPGP, LULU, and CRM can make great long-term investments. 
Via InvestorPlace
The 7 Most Undervalued Stocks to Buy for June 2022
The most undervalued stocks to buy right now are trading at attractive valuations and poised for big gains in the future. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022
Upgrades 
Via Benzinga
Five Ways To Play A Stock Market Reprieve
Eli Lilly and Albemarle lead 5 stocks that may be poised to lead the way higher. 
Via Investor's Business Daily
Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices
Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
Upgrades 
Via Benzinga
Cigna's Return On Capital Employed Insights
Pulled from Benzinga Pro data, Cigna (NYSE:CI) posted Q1 earnings of $1.20 billion, an increase from Q4 of 5.74%. Sales dropped to $44.11 billion, a 3.43% decrease between quarters. 
Via Benzinga
10 Biggest Price Target Changes For Monday
Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading. 
Via Benzinga
Cigna Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
Managed care Cigna stock had its Relative Strength (RS) Rating upgraded from to 92 Friday from 89 a day earlier. 
Via Investor's Business Daily
Peering Into Cigna's Recent Short Interest
Cigna's (NYSE:CI) short percent of float has fallen 15.67% since its last report. The company recently reported that it has 3.53 million shares sold short, which is 1.13% of all... 
Via Benzinga
Bulls Look To Bounce Back After Bear Barrage
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Recap: Cigna Q1 Earnings
Cigna (NYSE:CI) reported its Q1 earnings results on Friday, May 6, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Cigna beat estimated earnings by 16.02%,... 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.